CLINICAL_TRIALS
trial_result
· 2017-12-06
Clinical Trial Update: Study of the Safety of QRH-882260 Heptapeptide [Phase 1]
Summary
Phase 1 safety trial of QRH-882260 heptapeptide in healthy adults has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Michigan | Conditions: Healthy Adults | Phase 1 | Status: COMPLETED | Results posted: 2017-12-06